Medicinal Chemistry 2
A.Y. 2022/2023
Learning objectives
The most important learning objective of the course is to transmit a rational approach to understanding the activity of drugs and their design.
The participants at the end of the course will be able to understand the relationships that link the chemical structure of a drug to its pharmacological activity through the study of the physico-chemical and stereo-electronic properties, and of the mechanism of action.
The aim of the course is also the study of the main chemical-pharmaceutical strategies useful for the optimization of the pharmacodynamic and pharmacokinetic properties of drugs.
In particular, starting from the knowledge acquired in the course of Medicinal and Toxicological Chemistry 1, the course deals with the study of drugs active on the central and peripheral nervous system, cardiovascular agents, non-steroidal anti-inflammatory drugs, antihistamines, antiulcer and lipid-lowering drugs.
The participants at the end of the course will be able to understand the relationships that link the chemical structure of a drug to its pharmacological activity through the study of the physico-chemical and stereo-electronic properties, and of the mechanism of action.
The aim of the course is also the study of the main chemical-pharmaceutical strategies useful for the optimization of the pharmacodynamic and pharmacokinetic properties of drugs.
In particular, starting from the knowledge acquired in the course of Medicinal and Toxicological Chemistry 1, the course deals with the study of drugs active on the central and peripheral nervous system, cardiovascular agents, non-steroidal anti-inflammatory drugs, antihistamines, antiulcer and lipid-lowering drugs.
Expected learning outcomes
By the end of the course, students will have to know, for the different classes of drugs studied, how the prototype was discovered and the main steps through which the class was developed. Therefore, starting from the structure of a model compound, students should know how the structure can be modified in order to increase its activity and selectivity, optimize the pharmacokinetic properties and decrease toxicity. For each molecule studied, students should also be able to frame it correctly from the point of view of therapeutic application and mechanism of action, identify the essential pharmacophore and its mode of interaction with the target, if known, and they should be able to comment the structure-activity relationships.
Lesson period: Activity scheduled over several sessions (see Course syllabus and organization section for more detailed information).
Assessment methods: Esame
Assessment result: voto verbalizzato in trentesimi
Single course
This course cannot be attended as a single course. Please check our list of single courses to find the ones available for enrolment.
Course syllabus and organization
Linea AL
Responsible
Lesson period
year
CHIM/08 - PHARMACEUTICAL CHEMISTRY - University credits: 10
Lessons: 80 hours
Professor:
Conti Paola
Linea MZ
Responsible
Lesson period
year
Course syllabus
The program is focused on the study of drugs that act the following levels:
a) Parasympathetic neurotransmission: nicotinic and muscarinic agonists and antagonists, acetylcholinesterase inhibitors.
b) Sympathetic neurotransmission: adrenergic receptors agonists and antagonists, MAO and COMT inhibitors.
c) Cardio-circulatory system: cardiac glycosides, antianginal, antiarrhythmic, calcium channel blockers, potassium channel activators, ACE inhibitors, angiotensin antagonists, renin inhibitors, diuretics, lipid-lowering agents, antiplatelet agents and anticoagulants.
d) Respiratory, and gastric systems: anti-allergy, anti-ulcer, anti-asthma and hypoglycemic drugs.
e) Inflammation: Nonsteroidal (NSAIDs) and steroidal anti-inflammatory drugs.
f) Central nervous system: analgesics, local and general anesthetics, anxiolytics and hypnotic-sedatives, anticonvulsants, antiparkinson, , antipsychotics, antidepressants, stimulants and related substances of abuse.
Particular emphasis will be given to the study of:
a) Mechanisms of action of drugs: study of biomolecular processes involving neurotransmitters, neuromodulators, second messengers; study of structural characteristics (stereo-electronic requirements, topology, topography, conformational equilibria) of drugs (ligands) for the interaction with the main molecular targets (receptors, enzymes, ion channels).
b) Discovery and development of drugs: structural modifications of biologically active natural compounds; effect of the variation of molecular portions of lead compounds on affinity-activity-selectivity-bioavailability profiles.
a) Parasympathetic neurotransmission: nicotinic and muscarinic agonists and antagonists, acetylcholinesterase inhibitors.
b) Sympathetic neurotransmission: adrenergic receptors agonists and antagonists, MAO and COMT inhibitors.
c) Cardio-circulatory system: cardiac glycosides, antianginal, antiarrhythmic, calcium channel blockers, potassium channel activators, ACE inhibitors, angiotensin antagonists, renin inhibitors, diuretics, lipid-lowering agents, antiplatelet agents and anticoagulants.
d) Respiratory, and gastric systems: anti-allergy, anti-ulcer, anti-asthma and hypoglycemic drugs.
e) Inflammation: Nonsteroidal (NSAIDs) and steroidal anti-inflammatory drugs.
f) Central nervous system: analgesics, local and general anesthetics, anxiolytics and hypnotic-sedatives, anticonvulsants, antiparkinson, , antipsychotics, antidepressants, stimulants and related substances of abuse.
Particular emphasis will be given to the study of:
a) Mechanisms of action of drugs: study of biomolecular processes involving neurotransmitters, neuromodulators, second messengers; study of structural characteristics (stereo-electronic requirements, topology, topography, conformational equilibria) of drugs (ligands) for the interaction with the main molecular targets (receptors, enzymes, ion channels).
b) Discovery and development of drugs: structural modifications of biologically active natural compounds; effect of the variation of molecular portions of lead compounds on affinity-activity-selectivity-bioavailability profiles.
Prerequisites for admission
The course of Medicinal and toxicological chemistry 2 is the context in which the knowledge previously acquired in the courses of general and inorganic chemistry and, above all, of organic chemistry, biochemistry and medicinal and toxicological chemistry 1 are applied to the study of the drugs' mechanism of action and development.
Teaching methods
Frontal lessons with diapo projection.
Lessons attendance is strongly advised.
Lessons attendance is strongly advised.
Teaching Resources
Diapo and recordings of the lessons will be available online at: http://sromeocft2mz.ariel.ctu.unimi.it/
Students can choose one of the following books for the study of the subject:
a) Gasco, Gualtieri, Melchiorre: "Chimica Farmaceutica" Casa Editrice Ambrosiana, last Ed.
b) T. L. Lemke, D. A. Williams: "Foye's Principi di Chimica Farmaceutica", Piccin Editore, last Ed.
available online:
https://pharmacy.lwwhealthlibrary.com/book.aspx?bookid=2728
c) G. L. Patrick: "Introduzione alla Chimica Farmaceutica", EdiSES, last Ed.
In addition, students can use the following books to deepen some topics that will be reported during the lessons:
a) "Goodman & Gilman's The Pharmacological Basis of Therapeutics", McGraw-Hill Medical Publishing Division, last Ed. available online
https://accessmedicine.mhmedical.com/book.aspx?bookid=2189
b) Analogue Based Drug Discovery vol I, vol II & vol III.
available online:
https://onlinelibrary.wiley.com/doi/book/10.1002/3527608001
https://onlinelibrary.wiley.com/doi/book/10.1002/9783527630035
https://onlinelibrary.wiley.com/doi/book/10.1002/9783527651085
Students can choose one of the following books for the study of the subject:
a) Gasco, Gualtieri, Melchiorre: "Chimica Farmaceutica" Casa Editrice Ambrosiana, last Ed.
b) T. L. Lemke, D. A. Williams: "Foye's Principi di Chimica Farmaceutica", Piccin Editore, last Ed.
available online:
https://pharmacy.lwwhealthlibrary.com/book.aspx?bookid=2728
c) G. L. Patrick: "Introduzione alla Chimica Farmaceutica", EdiSES, last Ed.
In addition, students can use the following books to deepen some topics that will be reported during the lessons:
a) "Goodman & Gilman's The Pharmacological Basis of Therapeutics", McGraw-Hill Medical Publishing Division, last Ed. available online
https://accessmedicine.mhmedical.com/book.aspx?bookid=2189
b) Analogue Based Drug Discovery vol I, vol II & vol III.
available online:
https://onlinelibrary.wiley.com/doi/book/10.1002/3527608001
https://onlinelibrary.wiley.com/doi/book/10.1002/9783527630035
https://onlinelibrary.wiley.com/doi/book/10.1002/9783527651085
Assessment methods and Criteria
Students have seven exam sessions available each academic year. Students can present themselves to all exam sessions (there is no jump of session). On request it is possible to open extraordinary sessions reserved for students who are out of course or repeating.
The overall exam consists of a written test which, if judged sufficient, is followed by an oral test.
The written test, lasting 120 minutes, to be carried out without the help of notes or books, consists of 4 questions of equal weight for the calculation of the score out of thirty.
The questions focus on the discussion of the development, of the structure-activity relationships, of the interactions with specific targets and of the physico-chemical properties of the drugs treated in the program; questions include writing the drug structure.
After the correction of the written exams, which takes place within one week, the student is summoned for the oral exam. This consists of:
- a review of the written test in which the student is informed about the results of the correction.
- two questions relating to the whole program, aimed at ascertaining the ability to critically expose and argue the knowledge acquired.
The written test and the oral test have equal weight on the final grade.
As an alternative to the overall exam, students have the opportunity to take two in itinere tests lasting 120 minutes each in written form, respectively in February and July.
Each in itinere test includes 4 questions of a general nature. Passing both tests corresponds to passing the overall exam.
The overall exam consists of a written test which, if judged sufficient, is followed by an oral test.
The written test, lasting 120 minutes, to be carried out without the help of notes or books, consists of 4 questions of equal weight for the calculation of the score out of thirty.
The questions focus on the discussion of the development, of the structure-activity relationships, of the interactions with specific targets and of the physico-chemical properties of the drugs treated in the program; questions include writing the drug structure.
After the correction of the written exams, which takes place within one week, the student is summoned for the oral exam. This consists of:
- a review of the written test in which the student is informed about the results of the correction.
- two questions relating to the whole program, aimed at ascertaining the ability to critically expose and argue the knowledge acquired.
The written test and the oral test have equal weight on the final grade.
As an alternative to the overall exam, students have the opportunity to take two in itinere tests lasting 120 minutes each in written form, respectively in February and July.
Each in itinere test includes 4 questions of a general nature. Passing both tests corresponds to passing the overall exam.
CHIM/08 - PHARMACEUTICAL CHEMISTRY - University credits: 10
Lessons: 80 hours
Professor:
Romeo Sergio
Professor(s)
Reception:
By appointment
Via Mangiagalli 25 - 2° piano
Reception:
Monday 10:30-12:30, by appointment via email
Via Mangiagalli 25, second floor, office 2062